Stanley Laman Group, Ltd. Adaptive Biotechnologies Corp Transaction History

Stanley Laman Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$6.4 - $14.73 $53,043 - $122,082	8,288 Added 7.78%	114,780 $929,000
Q1 2022 Apr 21, 2022	BUY	$10.12 - $28.9 $459,761 - $1.31 Million	45,431 Added 74.4%	106,492 $1.48 Million
Q4 2021 Jan 25, 2022	BUY	$25.17 - $36.85 $1.12 Million - $1.63 Million	44,364 Added 265.7%	61,061 $1.71 Million
Q3 2021 Nov 03, 2021	BUY	$30.02 - $39.87 $501,243 - $665,709	16,697 New	16,697 $568,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.